Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Chromatin Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA040398 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA040398, RRID:AB_10673267
- Product name
- Anti-KLF5
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human KLF5, Gene description: Kruppel-like factor 5 (intestinal), Alternative Gene Names: BTEB2, CKLF, IKLF, Validated applications: IHC, ChIP, ICC, Uniprot ID: Q13887, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Genome-Wide Profiling Reveals HPV Integration Pattern and Activated Carcinogenic Pathways in Penile Squamous Cell Carcinoma
Prognostic Value and Function of KLF5 in Papillary Thyroid Cancer
Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma
Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality
Huang K, Guo S, Li Y, Zhang X, Chen D, Spiess P, Li Z, Deng C, Chen J, Zhou Q, Hu Z, Ma X, Jin J, Cao Y, Luo J, Wang X, Zhou F, Liu R, Han H
Cancers 2021;13(23):6104
Cancers 2021;13(23):6104
Prognostic Value and Function of KLF5 in Papillary Thyroid Cancer
Pratheeshkumar P, Siraj A, Divya S, Parvathareddy S, Siraj S, Diaz R, Begum R, Al-Sobhi S, Al-Dayel F, Al-Kuraya K
Cancers 2021;13(2):185
Cancers 2021;13(2):185
Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
Siraj A, Pratheeshkumar P, Divya S, Parvathareddy S, Alobaisi K, Thangavel S, Siraj S, Al-Badawi I, Al-Dayel F, Al-Kuraya K
Frontiers in Pharmacology 2020;11
Frontiers in Pharmacology 2020;11
DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma
Fu R, He W, Wang X, Li L, Zhao H, Liu X, Pang Z, Chen G, Huang L, Zhao K
Cell Death & Disease 2017;8(7):e2952-e2952
Cell Death & Disease 2017;8(7):e2952-e2952
Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality
Zimmerlin L, Park T, Huo J, Verma K, Pather S, Talbot C, Agarwal J, Steppan D, Zhang Y, Considine M, Guo H, Zhong X, Gutierrez C, Cope L, Canto-Soler M, Friedman A, Baylin S, Zambidis E
Development 2016;143(23):4368-4380
Development 2016;143(23):4368-4380
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- ChIP-Exo-Seq composite graph for Anti-KLF5 (HPA040398, Lot 000046764) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.